90 related articles for article (PubMed ID: 27693801)
1. The α2β3γ2 GABA
Spröte C; Richter F; Bauer A; Gerstenberger J; Richter A
Eur J Pharmacol; 2016 Nov; 791():655-658. PubMed ID: 27693801
[TBL] [Abstract][Full Text] [Related]
2. Probing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABA
Söderhielm PC; Balle T; Bak-Nyhus S; Zhang M; Hansen KM; Ahring PK; Jensen AA
Biochem Pharmacol; 2018 Dec; 158():339-358. PubMed ID: 30121248
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and autoradiographic studies on the pathophysiological role of GABA(B) receptors in the dystonic hamster: pronounced antidystonic effects of baclofen after striatal injections.
Sander SE; Richter F; Raymond R; Diwan M; Lange N; Nobrega JN; Richter A
Neuroscience; 2009 Aug; 162(2):423-30. PubMed ID: 19427369
[TBL] [Abstract][Full Text] [Related]
4. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
[TBL] [Abstract][Full Text] [Related]
5. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
[TBL] [Abstract][Full Text] [Related]
6. The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dt(sz) mutant hamster.
Richter A; Hamann M
Eur J Pharmacol; 2004 Oct; 502(1-2):105-8. PubMed ID: 15464095
[TBL] [Abstract][Full Text] [Related]
7. Effects of rubral microinjections of muscimol and bicuculline in a genetic animal model of paroxysmal dystonia.
Hamann M; Richter A
Brain Res; 2004 May; 1008(1):126-30. PubMed ID: 15081391
[TBL] [Abstract][Full Text] [Related]
8. Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia.
Hamann M; Richter A
Eur J Pharmacol; 2002 May; 443(1-3):59-70. PubMed ID: 12044793
[TBL] [Abstract][Full Text] [Related]
9. Altered postnatal maturation of striatal GABAergic interneurons in a phenotypic animal model of dystonia.
Bode C; Richter F; Spröte C; Brigadski T; Bauer A; Fietz S; Fritschy JM; Richter A
Exp Neurol; 2017 Jan; 287(Pt 1):44-53. PubMed ID: 27780732
[TBL] [Abstract][Full Text] [Related]
10. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.
Hamann M; Sander SE; Kreil A; Richter A
J Neural Transm (Vienna); 2010 Jun; 117(6):747-57. PubMed ID: 20454986
[TBL] [Abstract][Full Text] [Related]
11. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of neurosteroids in a rodent model of primary paroxysmal dystonia.
Hamann M; Richter F; Richter A
Horm Behav; 2007 Aug; 52(2):220-7. PubMed ID: 17553499
[TBL] [Abstract][Full Text] [Related]
13. Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.
Sander SE; Richter A
Eur J Pharmacol; 2007 Jun; 563(1-3):102-8. PubMed ID: 17349621
[TBL] [Abstract][Full Text] [Related]
14. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.
Gernert M; Hamann M; Bennay M; Löscher W; Richter A
J Neurosci; 2000 Sep; 20(18):7052-8. PubMed ID: 10995851
[TBL] [Abstract][Full Text] [Related]
15. Expression of metabotropic glutamate 5 receptors in the striatum and cortex and effects of modulators on the severity of dystonia in the phenotypic dt
Perl S; Richter F; Gericke B; Richter A
Eur J Pharmacol; 2019 Sep; 859():172527. PubMed ID: 31283933
[TBL] [Abstract][Full Text] [Related]
16. Lower KV7.5 Potassium Channel Subunit Expression in an Animal Model of Paroxysmal Dystonia.
Sander SE; Diwan M; Raymond R; Nobrega JN; Richter A
CNS Neurol Disord Drug Targets; 2016; 15(1):95-101. PubMed ID: 26553166
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis.
Richter A; Löscher W
Eur J Pharmacol; 1999 Mar; 369(3):335-8. PubMed ID: 10225372
[TBL] [Abstract][Full Text] [Related]
18. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
Richter A; Löschmann PA; Löscher W
Br J Pharmacol; 2000 Nov; 131(5):921-6. PubMed ID: 11053212
[TBL] [Abstract][Full Text] [Related]
19. Brivaracetam and seletracetam, two new SV2A ligands, improve paroxysmal dystonia in the dt sz mutant hamster.
Hamann M; Sander SE; Richter A
Eur J Pharmacol; 2008 Dec; 601(1-3):99-102. PubMed ID: 19014930
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the effects of NS11394 and L-838417, α2/3 subunit-selective GABA(A) [corrected] receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function.
Hofmann M; Kordás KS; Gravius A; Bölcskei K; Parsons CG; Dekundy A; Danysz W; Dézsi L; Wittko-Schneider IM; Sághy K; Gyertyán I; Horváth C
Behav Pharmacol; 2012 Dec; 23(8):790-801. PubMed ID: 23075708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
